Nausea and vomiting (N&V) are among the most feared symptoms of cancer treatment. Since treatment-related N&V is predictable up to some extent, a systematic approach is recommended for prevention. Recently, ASCO has updated and released its' guideline for the prevention of treatment-related N&V. This paper is aimed to summarise the key changes and recommendations of ASCO for practicing medical or radiation oncologists treating adult cancer patients.

Keywords:

Palliative care, Nausea, Vomiting, NK1 antagonists, Olanzapine, 5HT3 antagonist, antiemetic prophylaxis